New York Post29d
FDA may outlaw food dyes ‘within weeks’: Bombshell move would affect candy, soda and cakes, revolutionize American diets
the deputy commissioner for human foods at the FDA, said during a Senate meeting this week, per NBC. According to the FDA, the agency has reviewed the safety of Red 3 —which is derived from ...
Acelyrin spikes on upcoming mid-stage data update on eye disease drug
Acelyrin (NASDAQ:SLRN) shares traded higher on Friday after the company scheduled an investor meeting for next week to ...
Dairy Foods13d
Revamping FDA’s post-market assessment for food chemicals
On Sept. 25, the U.S. Food and Drug Administration (FDA) hosted a public meeting to gather feedback on its proposed framework ...
The FDA’s Evolving Role in Public Health
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
BioPharma Dive17d
Zepbound, Mounjaro shortages are resolved, FDA confirms
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...
Nasdaq20d
MannKind Corporation to Discuss Afrezza Diabetes Study Results and Upcoming FDA Meeting Plans
MannKind expects to submit a request for a supplemental new drug application (sNDA) meeting with the U.S. Food and Drug Administration (FDA) in 1H 2025 to discuss the data and filing timeline.
Kansas City Star18d
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA
On December 17, 2024, the Company conducted a Submission Issue Request (SIR) meeting with the FDA. Management believes its comprehensive plans to address the Additional Information Request (AIR ...
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?
Kazia Therapeutics updates paxalisib's regulatory progress after FDA discussions on glioblastoma data, highlighting plans for ...